;

1.94 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/23/2024 8:06:23 PM)
Exchange closed, opens in 13 hours 23 minutes
3.19 USD (3.19%)
-2.02 USD (-2.02%)
-23.62 USD (-23.62%)
-33.79 USD (-33.79%)
-16.38 USD (-16.38%)
-39.38 USD (-39.38%)
-99.83 USD (-99.83%)
-100.00 USD (-100.00%)

About Armata Pharmaceuticals

Market Capitalization 71.64M

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

Headquarters (address)

5005 McConnell Avenue

Los Angeles 90066 CA

United States

Phone310 665 2928
Websitehttps://www.armatapharma.com
Employees66
SectorHealthcare
IndustryBiotechnology
TickerARMP
ExchangeNew York Stock Exchange
CurrencyUSD
52 week range1.89 - 4.48
Market Capitalization71.64M
P/E trailing-1.02
P/E forward-1.26
Price/Sale19.26
Price/Book-1.38
Beta3.00
EPS-1.15
EPS United States (ID:6, base:3382) 24.33

CleverShares.com|
2024 ©

1.0.9119.29486